LUCRETIA HULL: Open Payments
NPI 1922876416 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,089 in 72 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $218 · 2025 $2,089
Food & beverage: $2,089
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $389 |
| Novo Nordisk Inc | 9 | $271 |
| Dexcom, Inc. | 7 | $183 |
| Amgen Inc. | 5 | $179 |
| ViiV Healthcare Company | 3 | $166 |
| Abbott Laboratories | 1 | $155 |
| PFIZER INC. | 4 | $72 |
| Viatris Specialty LLC | 3 | $67 |
| Antares Pharma, Inc. | 4 | $66 |
| Phathom Pharmaceuticals, Inc. | 4 | $57 |
Products named: Ozempic, APRETUDE, FREESTYLE LIBRE 3, BREZTRI, AIRSUPRA, DEXCOM G7 GSS (161), REPATHA, FARXIGA.
Industry payments across NV — which companies pay providers there.
